Recent updates in chronic obstructive pulmonary disease

References

• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) [Internet]. 2015. [ cited 2015 Jul 12]. Available from: http://www.goldcopd.org/
   Google Scholar
• World Health Organization. Chronic respiratory diseases: burden of COPD [Internet]. 2015 [ cited 2015 Oct 9]. Available from: http://www.who.int/respiratory/copd/burden/en/
   Google Scholar
• Hoyert DL, Xu JQ. Deaths: preliminary data for 2011. Hyattsville, MD: National Center for Health Statistics 2012. Natl Vital Stat Rep. 2012;61(6):1–65.
   PubMedGoogle Scholar
• Prevention. CfDCa. Chronic obstructive pulmonary disease among adults—United States. 2011. MMWR. 2012;61(46):938–943.
   PubMedGoogle Scholar
• Porszasz J, Emtner M, Goto S, et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest. 2005;128(4):2025–2034.
   PubMed Web of Science ®Google Scholar
• Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105(1):57–66.
   PubMed Web of Science ®Google Scholar
• Van Dijk W, Tan W, Li P, et al. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Ann Fam Med. 2015;13(1):41–48.
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
   PubMed Web of Science ®Google Scholar
• Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880–887.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654.
   PubMed Web of Science ®Google Scholar
• Van Der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
   PubMedGoogle Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012.
   PubMed Web of Science ®Google Scholar
• Cunningham TJ, Ford ES, Rolle IV, et al. Associations of self-reported cigarette smoking with chronic obstructive pulmonary disease and co-morbid chronic conditions in the United States. COPD. 2015;12(3):276–286.
   Google Scholar
• O’Donnell DE, Gebke KB. Examining the role of activity, exercise, and pharmacology in mild COPD. Postgrad Med. 2014;126(5):135–145.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–191.
   PubMed Web of Science ®Google Scholar
• Garvey C. Identification of patients with early COPD. Curr Respir Med Rev. 2014;9(6):407–417.
   Google Scholar
• Egan C, Deering BM, Blake C, et al. Short term and long term effects of pulmonary rehabilitation on physical activity in COPD. Respir Med. 2012;106(12):1671–1679.
   PubMed Web of Science ®Google Scholar
• Marchetti N, Criner GJ. Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation. Semin Respir Crit Care Med. 2015;36(4):592–608.
   PubMed Web of Science ®Google Scholar
• Mineshita M, Slebos DJ. Bronchoscopic interventions for chronic obstructive pulmonary disease. Respirology. 2014;19(8):1126–1137.
   PubMed Web of Science ®Google Scholar
• Deslee G, Klooster K, Hetzel M, et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014;69(11):980–986.
   PubMed Web of Science ®Google Scholar
• Gagnon P, Saey D, Provencher S, et al. Walking exercise response to bronchodilation in mild COPD: a randomized trial. Respir Med. 2012;106(12):1695–1705.
   PubMed Web of Science ®Google Scholar
• Singh D. New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives. Br J Clin Pharmacol. 2015;79(5):695–708.
   PubMed Web of Science ®Google Scholar
• Buhl R, Maltais F, Abrahams R, et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4). Eur Respir J. 2015;45(4):969–979.
   PubMed Web of Science ®Google Scholar
• Blair HA, Deeks ED. Umeclidinium/Vilanterol: a review of its use as maintenance therapy in adults with chronic obstructive pulmonary disease. Drugs. 2015;75(1):61–74.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Maselli R, Matera MG. Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol/glycopyrronium. Pharmacology. 2014;94(5–6):249–258.
   PubMed Web of Science ®Google Scholar
• Troosters T, Sciurba FC, Decramer M, et al. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial. NPJ Prim Care Respir Med. 2014;24:14003.
   PubMed Web of Science ®Google Scholar
• Clark TW, Medina MJ, Batham S, et al. C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD. Eur Respir J. 2015;45(1):76–86.
   PubMed Web of Science ®Google Scholar
• Wu X, Chen D, Gu X, et al. Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis. Mol Biol Rep. 2014;41(7):4743–4751.
   PubMed Web of Science ®Google Scholar
• Garvey C, Ortiz G. Exacerbations of chronic obstructive pulmonary disease. Open Nurs J. 2012;6:13–19.
   PubMedGoogle Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138.
   PubMed Web of Science ®Google Scholar
• Magda S. Susceptibility to exacerbation in chronic obstructive pulmonary disease - data from the ECLIPSE study. Maedica (Buchar)</I>. 2010;5(3):223–224.
   PubMedGoogle Scholar
• Wedzicha JA, Brill SE, Allinson JP, et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013;11:181.
   PubMed Web of Science ®Google Scholar
• Overbeek JA, Penning-van Beest FJ, Balp MM, et al. Burden of exacerbations in patients with moderate to very severe COPD in the Netherlands: a real-life study. COPD. 2015;12(2):132–143.
   PubMedGoogle Scholar
• Alahmari AD, Patel AR, Kowlessar BS, et al. Daily activity during stability and exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med. 2014;14:98.
   PubMed Web of Science ®Google Scholar
• Rubinsztajn R, Przybylowski T, Maskey-Warzechowska M, et al. Effect of exacerbation frequency on body composition and serum ghrelin and adiponectin concentrations in patients with chronic obstructive pulmonary disease. Pol Arch Med Wewn. 2014;124(7–8):403–409.
   PubMed Web of Science ®Google Scholar
• Nici L, ZuWallack R. An official American Thoracic Society workshop report: the integrated care of the COPD patient. Proc Am Thorac Soc. 2012;9(1):9–18.
   PubMedGoogle Scholar
• Woods JA, Wheeler JS, Finch CK, et al. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:421–430.
   PubMed Web of Science ®Google Scholar
• Leuppi JD, Schuetz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013;309(21):2223–2231.
   PubMed Web of Science ®Google Scholar
• Jo YS, Choi SM, Lee J, et al. The relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNHANES 2010-2012. Respir Med. 2015;109(1):96–104.
   PubMed Web of Science ®Google Scholar
• Echave-Sustaeta JM, Comeche Casanova L, Cosio BG, et al. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? Int J Chron Obstruct Pulmon Dis. 2014;9:1307–1314.
   PubMed Web of Science ®Google Scholar
• Sidney S, Sorel M, Quesenberry CP Jr., et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068–2075.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med. 2006;100(1):115–122.
   PubMed Web of Science ®Google Scholar
• Black-Shinn JL, Kinney GL, Wise AL, et al. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. Copd. 2014;11(5):546–551.
   PubMedGoogle Scholar
• Sievi NA, Senn O, Brack T, et al. Impact of comorbidities on physical activity in COPD. Respirology. 2015;20(3):413–418.
   PubMed Web of Science ®Google Scholar
• McNamara RJ, McKeough ZJ, McKenzie DK, et al. Physical comorbidities affect physical activity in chronic obstructive pulmonary disease: a prospective cohort study. Respirology. 2014;19(6):866–872.
   PubMed Web of Science ®Google Scholar
• Huang B, Yang Y, Zhu J, et al. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study. J Am Med Dir Assoc. 2014;15(8):576–581.
   PubMed Web of Science ®Google Scholar
• Fisher K, Stefan M, Darling C, et al. Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure (The Worcester Heart Failure Study). Chest. 2015;147(3):637–645.
   Web of Science ®Google Scholar
• Carlin BW. COPD and associated comorbidities: a review of current diagnosis and treatment. Postgrad Med. 2012;124(4):225–240.
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L, Spruit MA, Van Den Borne BE, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med. 2009;103(8):1143–1151.
   PubMed Web of Science ®Google Scholar
• Cielen N, Maes K, Gayan-Ramirez G. Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int. 2014;2014:965764.
   PubMed Web of Science ®Google Scholar
• Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr Opin Pulm Med. 2009;15(2):143–149.
   PubMed Web of Science ®Google Scholar
• Pumar MI, Gray CR, Walsh JR, et al. Anxiety and depression-important psychological comorbidities of COPD. J Thorac Dis. 2014;6(11):1615–1631.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349.
   PubMedGoogle Scholar
• Raviv S, Hawkins KA, DeCamp MM Jr., et al. Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes. Am J Respir Crit Care Med. 2011;183(9):1138–1146.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Enright PL, et al. Lung Health Study Research G. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166(3):333–339.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee J, Park YS, et al. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer. J Thorac Oncol. 2014;9(6):812–817.
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax. 2006;61(3):250–258.
   PubMed Web of Science ®Google Scholar
• Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):400–407.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, De La Rosa Carrillo D, Soler-Cataluna JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(8):823–831.
   PubMed Web of Science ®Google Scholar
• Caughey GE, Preiss AK, Vitry AI, et al. Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications. Diabetes Care. 2013;36(10):3009–3014.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Calzetta L, Segreti A, et al. Diabetes mellitus among outpatients with COPD attending a university hospital. Acta Diabetol. 2014;51(6):933–940.
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Soriano JB, Miravitlles M, et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One. 2014;9(8):e105220.
   PubMed Web of Science ®Google Scholar
• Kumar R, Nagar D, Mallick A, et al. Obstructive sleep apnoea and atopy among middle aged chronic obstructive pulmonary disease and bronchial asthma patients. J Assoc Physicians India. 2013;61(9):615–618.
   PubMedGoogle Scholar
• Li CH, Chen WC, Liao WC, et al. The association between chronic obstructive pulmonary disease and Parkinson’s disease: a nationwide population-based retrospective cohort study. QJM. 2015;108(1):39–45.
   PubMed Web of Science ®Google Scholar
• Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009;135(3):786–793.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Chou R, Humphrey LL, et al. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;155(9):625–632.
   PubMed Web of Science ®Google Scholar
• Budweiser S, Harlacher M, Pfeifer M, et al. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD. Copd. 2014;11(4):388–400.
   PubMedGoogle Scholar
• Vitacca M, Paneroni M, Peroni R, et al. Effects of a multidisciplinary care program on disability, autonomy, and nursing needs in subjects recovering from acute respiratory failure in a chronic ventilator facility. Respir Care. 2014;59(12):1863–1871.
   PubMed Web of Science ®Google Scholar
• Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J. 2009;34(4):812–818.
   PubMed Web of Science ®Google Scholar
• Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax. 2008;63(9):761–767.
   PubMed Web of Science ®Google Scholar
• Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48(3):279–285.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331–337.
   PubMed Web of Science ®Google Scholar
• Alshabanat A, Zafari Z, Albanyan O, et al. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10(9):e0136065.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Pitta F. Promoting regular physical activity in pulmonary rehabilitation. Clin Chest Med. 2014;35(2):363–368.
   PubMed Web of Science ®Google Scholar
• Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(6):622–629.
   PubMed Web of Science ®Google Scholar
• Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119(10 Suppl 1):21–31.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med. 2007;175(5):458–463.
   PubMed Web of Science ®Google Scholar
• Nguyen HQ, Chu L, Amy Liu IL, et al. Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(5):695–705.
   PubMedGoogle Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342.
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Rojo B, Casitas R, et al. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012;142(2):338–346.
   PubMed Web of Science ®Google Scholar
• Chawla H, Bulathsinghala C, Tejada JP, et al. Physical activity as a predictor of thirty-day hospital readmission after a discharge for a clinical exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(8):1203–1209.
   PubMedGoogle Scholar
• Rehabilitation. AAoCP. Guidelines for Pulmonary Rehabilitation Programs Fourth Edition. Chicago (IL): American Association of Cardiovascular & Pulmonary Rehabilitation, Inc.; 2010. p. 45.
   Google Scholar
• Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155(5):1541–1551.
   PubMed Web of Science ®Google Scholar
• Subin RV, Prem V, Sahoo. Effect of upper limb, lower limb and combined training on health-related quality of life in COPD. Lung India. 2010;27(1):4–7.
   PubMedGoogle Scholar
• Wootton SL, Ng LW, McKeough ZJ, et al. Ground-based walking training improves quality of life and exercise capacity in COPD. Eur Respir J. 2014;44(4):885–894.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R, Garcia-Aymerich J. Should we exercise caution with benzodiazepine use in patients with COPD? Eur Respir J. 2014;44(2):284–286.
   PubMed Web of Science ®Google Scholar
• De Sousa Pinto JM, Martin-Nogueras AM, Calvo-Arenillas JI, et al. Clinical benefits of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2014;34(5):355–359.
   PubMed Web of Science ®Google Scholar
• Lan CC, Huang HC, Yang MC, et al. Pulmonary rehabilitation improves subjective sleep quality in COPD. Respir Care. 2014;59(10):1569–1576.
   PubMed Web of Science ®Google Scholar
• Cheng ST, Wu YK, Yang MC, et al. Pulmonary rehabilitation improves heart rate variability at peak exercise, exercise capacity and health-related quality of life in chronic obstructive pulmonary disease. Heart Lung. 2014;43(3):249–255.
   PubMed Web of Science ®Google Scholar
• Cameron-Tucker HL, Wood-Baker R, Owen C, et al. Chronic disease self-management and exercise in COPD as pulmonary rehabilitation: a randomized controlled trial. Int J Chron Obstruct Pulmon Dis. 2014;9:513–523.
   PubMed Web of Science ®Google Scholar
• Zwerink M, Van Der Palen J, Kerstjens HA, et al. A community-based exercise programme in COPD self-management: two years follow-up of the COPE-II study. Respir Med. 2014;108(10):1481–1490.
   PubMed Web of Science ®Google Scholar
• Fletcher MJ, Dahl BH. Expanding nurse practice in COPD: is it key to providing high quality, effective and safe patient care? Prim Care Respir J. 2013;22(2):230–233.
   PubMedGoogle Scholar
• Mannino DM. Biomarkers in COPD: the search continues! Eur Respir J. 2015;45(4):872–874.
   PubMed Web of Science ®Google Scholar